Kuan-Hsun Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kuan-Hsun Lin has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Tsai-Wang Huang
Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan
9 shared publications - Ying-Shian Chen
Department of Thoracic Surgery, School of Medicine, College of Medicine, National Defense Medical University, Taipei, Taiwan
5 shared publications - Hsu-Kai Huang
Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan
4 shared publications - Cheng-Jung Lin
Department of Thoracic Surgery, School of Medicine, College of Medicine, National Defense Medical University, Taipei, Taiwan
3 shared publications - Ding-Han Wang
College of Dentistry, National Yang Ming Chiao Tung University, Taipei, Taiwan
2 shared publications - Hsiang Teng
Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan
2 shared publications
Latest Publications
- Open Access
- 7 November 2026
- Published by Wolters Kluwer Health in Circulation
Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development (LATENT): A Randomized Controlled Trial
BACKGROUND: Electrocardiographic analysis aided by artificial intelligence (AI) may identify atrial electrical vulnerability during sinus rhythm. The objective of this study was to determine whether AI–enabled ECG (AI-ECG) is effective for detecting atrial fibrillation (AF), atrial flutter (AFl), or prespecified pre-AF atrial findings in a randomized trial. METHODS: In this single-center, open-label trial, 14 665 adults 40 to 85 years of age without previous AF/AFl were randomized to an AI-ECG–guided strategy or usual care. Participants randomized to AI-ECG who were then identified by AI as having a high-risk sinus-rhythm ECG in the preceding year were offered Holter monitoring for ≤7 days. Each monitored high-risk intervention participant was paired with an age- and sex-matched control selected before control ECGs underwent AI analysis. Matched controls received identical monitoring to reduce ascertainment bias. Reporting cardiologists were blinded to AI results and randomized assignment. The primary outcome was a composite of newly detected AF, AFl, or pre-AF atrial findings within 90 days. Pre-AF atrial findings comprised frequent premature atrial complexes, short runs of premature atrial complexes, or nonsustained AF/AFl. RESULTS: Among 7337 intervention and 7328 control participants, 84 (1.1%) and 78 (1.1%), respectively, were classified as high risk. Of the 84 high-risk intervention participants, 48 (57.1%) underwent monitoring, as did 48 matched controls. The primary outcome occurred in 54 intervention participants (0.74%) versus 35 control participants (0.48%; odds ratio, 1.54 [95% CI, 1.01–2.37]; P =0.046). Hypothetical reclassification of 1 intervention event to a nonevent changed the primary analysis P value to 0.057. The intervention effect on detection of the primary composite outcome differed by baseline AI-ECG risk ( P interaction <0.001): 32.1% versus 2.6% among high-risk participants and 0.4% versus 0.5% among low-risk participants. AF/AFl detection (0.3% versus 0.2%) and antiarrhythmic therapy initiation at 180 days (2.3% versus 2.4%) did not differ significantly between the intervention and control groups. Participant-reported monitoring-related adverse events, including skin reactions and discomfort, occurred in 22.9% of monitored intervention participants versus 18.8% of matched controls. CONCLUSIONS: AI-ECG–guided monitoring resulted in a modest increase in the detection of new AF, AFl, or pre-AF atrial findings. However, these findings were fragile statistically and sensitive to reclassification of 1 event. LATENT (Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development) demonstrates the clinical application of AI-ECG risk stratification to guide targeted rhythm surveillance, providing a foundation for larger trials evaluating its impact on patient outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT06847932.
- 7 November 2026
- Published by Wolters Kluwer Health in Circulation
Open AccessLeveraging AI-ECG Technology for Early Notification and Tracking of AF Development (LATENT): A Randomized Controlled Trial
BACKGROUND: Electrocardiographic analysis aided by artificial intelligence (AI) may identify atrial electrical vulnerability during sinus rhythm. The objective of this study was to determine whether AI–enabled ECG (AI-ECG) is effective for detecting atrial fibrillation (AF), atrial flutter (AFl), or prespecified pre-AF atrial findings in a randomized trial. METHODS: In this single-center, open-label trial, 14 665 adults 40 to 85 years of age without previous AF/AFl were randomized to an AI-ECG–guided strategy or usual care. Participants randomized to AI-ECG who were then identified by AI as having a high-risk sinus-rhythm ECG in the preceding year were offered Holter monitoring for ≤7 days. Each monitored high-risk intervention participant was paired with an age- and sex-matched control selected before control ECGs underwent AI analysis. Matched controls received identical monitoring to reduce ascertainment bias. Reporting cardiologists were blinded to AI results and randomized assignment. The primary outcome was a composite of newly detected AF, AFl, or pre-AF atrial findings within 90 days. Pre-AF atrial findings comprised frequent premature atrial complexes, short runs of premature atrial complexes, or nonsustained AF/AFl. RESULTS: Among 7337 intervention and 7328 control participants, 84 (1.1%) and 78 (1.1%), respectively, were classified as high risk. Of the 84 high-risk intervention participants, 48 (57.1%) underwent monitoring, as did 48 matched controls. The primary outcome occurred in 54 intervention participants (0.74%) versus 35 control participants (0.48%; odds ratio, 1.54 [95% CI, 1.01–2.37]; P =0.046). Hypothetical reclassification of 1 intervention event to a nonevent changed the primary analysis P value to 0.057. The intervention effect on detection of the primary composite outcome differed by baseline AI-ECG risk ( P interaction <0.001): 32.1% versus 2.6% among high-risk participants and 0.4% versus 0.5% among low-risk participants. AF/AFl detection (0.3% versus 0.2%) and antiarrhythmic therapy initiation at 180 days (2.3% versus 2.4%) did not differ significantly between the intervention and control groups. Participant-reported monitoring-related adverse events, including skin reactions and discomfort, occurred in 22.9% of monitored intervention participants versus 18.8% of matched controls. CONCLUSIONS: AI-ECG–guided monitoring resulted in a modest increase in the detection of new AF, AFl, or pre-AF atrial findings. However, these findings were fragile statistically and sensitive to reclassification of 1 event. LATENT (Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development) demonstrates the clinical application of AI-ECG risk stratification to guide targeted rhythm surveillance, providing a foundation for larger trials evaluating its impact on patient outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT06847932.
- Open Access
- 9 September 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e94084
Real-Time AI-Augmented Fluoroscopic Navigation for Intraoperative Pulmonary Nodule Localization: Prospective Observational Pilot Study
Background: The integration of AI into intraoperative surgical imaging represents an emerging frontier in digital health. Despite advances in preoperative computed tomography (CT)–based surgical planning, real-time translation of imaging data into actionable intraoperative guidance remains limited by CT-to-body divergence—a fundamental information gap between preoperative digital models and the dynamic surgical field. This divergence, driven by lung deflation under anesthesia and positional changes, represents a critical digital-to-physical registration challenge that current preoperative imaging workflows fail to address in real time. Objective: This study aimed to evaluate the clinical feasibility, localization success, and safety of the LungVision system—an AI-augmented fluoroscopic navigation platform—for real-time intraoperative localization of small pulmonary nodules during thoracoscopic surgery. Methods: A prospective single-center study enrolled 14 patients with pulmonary nodules requiring localization prior to thoracoscopic resection between January 2024 and December 2024. The platform comprises a passive radiopaque positioning board, an AI-powered computing unit for real-time image processing, and a tablet-based interface for procedural planning and augmented visualization. All patients received dual localization with either preoperative CT-guided dye injection or Archimedes virtual bronchoscopic navigation followed by intraoperative localization with the LungVision system and video-assisted thoracoscopic surgery. Demographic data, lesion characteristics, procedural performance, and procedure-related complications were recorded. Results: The mean patient age was 57.2 (SD 9.2) years, and 92.9% (13/14) were nonsmokers. Most nodules were peripherally located (12/14, 85.7%), with a mean diameter of 9.3 (SD 5.3) mm and a mean CT attenuation of −320.1 (SD 334.9) Hounsfield units. LungVision successfully localized all target lesions intraoperatively, with a mean navigation time of 38.6 (SD 19.5) minutes. Complete resection was achieved in all cases, and 71.4% (10/14) of nodules were pathologically malignant. No intraoperative or localization-related complications were observed. The system was integrated into the existing operating room without additional infrastructure modifications. Conclusions: In this prospective study, the LungVision system achieved successful intraoperative localization of small, hypodense pulmonary nodules using a bronchoscopic approach integrated with conventional C-arm fluoroscopy. These findings support the feasibility of the technique and provide preliminary evidence on its use in thoracoscopic resection workflows. Larger studies are needed to further evaluate its clinical performance and implementation in diverse practice settings. Trial Registration: ClinicalTrials.gov NCT07682012; https://clinicaltrials.gov/study/NCT07682012
- 9 September 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e94084
Open AccessReal-Time AI-Augmented Fluoroscopic Navigation for Intraoperative Pulmonary Nodule Localization: Prospective Observational Pilot Study
Background: The integration of AI into intraoperative surgical imaging represents an emerging frontier in digital health. Despite advances in preoperative computed tomography (CT)–based surgical planning, real-time translation of imaging data into actionable intraoperative guidance remains limited by CT-to-body divergence—a fundamental information gap between preoperative digital models and the dynamic surgical field. This divergence, driven by lung deflation under anesthesia and positional changes, represents a critical digital-to-physical registration challenge that current preoperative imaging workflows fail to address in real time. Objective: This study aimed to evaluate the clinical feasibility, localization success, and safety of the LungVision system—an AI-augmented fluoroscopic navigation platform—for real-time intraoperative localization of small pulmonary nodules during thoracoscopic surgery. Methods: A prospective single-center study enrolled 14 patients with pulmonary nodules requiring localization prior to thoracoscopic resection between January 2024 and December 2024. The platform comprises a passive radiopaque positioning board, an AI-powered computing unit for real-time image processing, and a tablet-based interface for procedural planning and augmented visualization. All patients received dual localization with either preoperative CT-guided dye injection or Archimedes virtual bronchoscopic navigation followed by intraoperative localization with the LungVision system and video-assisted thoracoscopic surgery. Demographic data, lesion characteristics, procedural performance, and procedure-related complications were recorded. Results: The mean patient age was 57.2 (SD 9.2) years, and 92.9% (13/14) were nonsmokers. Most nodules were peripherally located (12/14, 85.7%), with a mean diameter of 9.3 (SD 5.3) mm and a mean CT attenuation of −320.1 (SD 334.9) Hounsfield units. LungVision successfully localized all target lesions intraoperatively, with a mean navigation time of 38.6 (SD 19.5) minutes. Complete resection was achieved in all cases, and 71.4% (10/14) of nodules were pathologically malignant. No intraoperative or localization-related complications were observed. The system was integrated into the existing operating room without additional infrastructure modifications. Conclusions: In this prospective study, the LungVision system achieved successful intraoperative localization of small, hypodense pulmonary nodules using a bronchoscopic approach integrated with conventional C-arm fluoroscopy. These findings support the feasibility of the technique and provide preliminary evidence on its use in thoracoscopic resection workflows. Larger studies are needed to further evaluate its clinical performance and implementation in diverse practice settings. Trial Registration: ClinicalTrials.gov NCT07682012; https://clinicaltrials.gov/study/NCT07682012
- Open Access
- 25 February 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Real-Time AI-Augmented Fluoroscopic Navigation for Intraoperative Pulmonary Nodule Localization: Prospective Observational Pilot Study (Preprint)
BACKGROUND The integration of AI into intraoperative surgical imaging represents an emerging frontier in digital health. Despite advances in preoperative computed tomography (CT)–based surgical planning, real-time translation of imaging data into actionable intraoperative guidance remains limited by CT-to-body divergence—a fundamental information gap between preoperative digital models and the dynamic surgical field. This divergence, driven by lung deflation under anesthesia and positional changes, represents a critical digital-to-physical registration challenge that current preoperative imaging workflows fail to address in real time. OBJECTIVE This study aimed to evaluate the clinical feasibility, localization success, and safety of the LungVision system—an AI-augmented fluoroscopic navigation platform—for real-time intraoperative localization of small pulmonary nodules during thoracoscopic surgery. METHODS A prospective single-center study enrolled 14 patients with pulmonary nodules requiring localization prior to thoracoscopic resection between January 2024 and December 2024. The platform comprises a passive radiopaque positioning board, an AI-powered computing unit for real-time image processing, and a tablet-based interface for procedural planning and augmented visualization. All patients received dual localization with either preoperative CT-guided dye injection or Archimedes virtual bronchoscopic navigation followed by intraoperative localization with the LungVision system and video-assisted thoracoscopic surgery. Demographic data, lesion characteristics, procedural performance, and procedure-related complications were recorded. RESULTS The mean patient age was 57.2 (SD 9.2) years, and 92.9% (13/14) were nonsmokers. Most nodules were peripherally located (12/14, 85.7%), with a mean diameter of 9.3 (SD 5.3) mm and a mean CT attenuation of −320.1 (SD 334.9) Hounsfield units. LungVision successfully localized all target lesions intraoperatively, with a mean navigation time of 38.6 (SD 19.5) minutes. Complete resection was achieved in all cases, and 71.4% (10/14) of nodules were pathologically malignant. No intraoperative or localization-related complications were observed. The system was integrated into the existing operating room without additional infrastructure modifications. CONCLUSIONS In this prospective study, the LungVision system achieved successful intraoperative localization of small, hypodense pulmonary nodules using a bronchoscopic approach integrated with conventional C-arm fluoroscopy. These findings support the feasibility of the technique and provide preliminary evidence on its use in thoracoscopic resection workflows. Larger studies are needed to further evaluate its clinical performance and implementation in diverse practice settings. CLINICALTRIAL ClinicalTrials.gov NCT07682012; https://clinicaltrials.gov/study/NCT07682012
- 25 February 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessReal-Time AI-Augmented Fluoroscopic Navigation for Intraoperative Pulmonary Nodule Localization: Prospective Observational Pilot Study (Preprint)
BACKGROUND The integration of AI into intraoperative surgical imaging represents an emerging frontier in digital health. Despite advances in preoperative computed tomography (CT)–based surgical planning, real-time translation of imaging data into actionable intraoperative guidance remains limited by CT-to-body divergence—a fundamental information gap between preoperative digital models and the dynamic surgical field. This divergence, driven by lung deflation under anesthesia and positional changes, represents a critical digital-to-physical registration challenge that current preoperative imaging workflows fail to address in real time. OBJECTIVE This study aimed to evaluate the clinical feasibility, localization success, and safety of the LungVision system—an AI-augmented fluoroscopic navigation platform—for real-time intraoperative localization of small pulmonary nodules during thoracoscopic surgery. METHODS A prospective single-center study enrolled 14 patients with pulmonary nodules requiring localization prior to thoracoscopic resection between January 2024 and December 2024. The platform comprises a passive radiopaque positioning board, an AI-powered computing unit for real-time image processing, and a tablet-based interface for procedural planning and augmented visualization. All patients received dual localization with either preoperative CT-guided dye injection or Archimedes virtual bronchoscopic navigation followed by intraoperative localization with the LungVision system and video-assisted thoracoscopic surgery. Demographic data, lesion characteristics, procedural performance, and procedure-related complications were recorded. RESULTS The mean patient age was 57.2 (SD 9.2) years, and 92.9% (13/14) were nonsmokers. Most nodules were peripherally located (12/14, 85.7%), with a mean diameter of 9.3 (SD 5.3) mm and a mean CT attenuation of −320.1 (SD 334.9) Hounsfield units. LungVision successfully localized all target lesions intraoperatively, with a mean navigation time of 38.6 (SD 19.5) minutes. Complete resection was achieved in all cases, and 71.4% (10/14) of nodules were pathologically malignant. No intraoperative or localization-related complications were observed. The system was integrated into the existing operating room without additional infrastructure modifications. CONCLUSIONS In this prospective study, the LungVision system achieved successful intraoperative localization of small, hypodense pulmonary nodules using a bronchoscopic approach integrated with conventional C-arm fluoroscopy. These findings support the feasibility of the technique and provide preliminary evidence on its use in thoracoscopic resection workflows. Larger studies are needed to further evaluate its clinical performance and implementation in diverse practice settings. CLINICALTRIAL ClinicalTrials.gov NCT07682012; https://clinicaltrials.gov/study/NCT07682012
- Open Access
- 20 December 2025
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 4 (2) , 521-524
Video-Assisted Thoracoscopic Resection of Cervicomediastinal Masses Using Preoperative Virtual 3-Dimensional Imaging
- 20 December 2025
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 4 (2) , 521-524
Open AccessVideo-Assisted Thoracoscopic Resection of Cervicomediastinal Masses Using Preoperative Virtual 3-Dimensional Imaging
- Open Access
- 13 November 2025
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 13, e79632
Effect of Mobile Augmented Reality Counseling on Improving Shared Decision-Making in Thoracic Surgery: Randomized Clinical Crossover Trial
Background: Augmented reality (AR) superimposes virtual objects onto a real-world environment, allowing users to interact in real time. As AR has become widely used, its integration into smartphones or tablets has enabled mobile augmented reality (MAR) experiences. AR has been adopted in many industries, and the literature has highlighted its applications in academic and clinical settings, particularly in enhancing visualization, communication, and learning. Objective: This study investigated the potential of MAR as a mobile health tool to enhance shared decision-making (SDM) in thoracic surgery by increasing patient understanding and engagement during medical consultations. Methods: A randomized crossover clinical trial was conducted at the Tri-Service General Hospital in Taiwan. Participants scheduled for thoracic surgery were enrolled and randomized in a crossover design. The MAR intervention incorporated patient-specific 3D anatomical models that were reconstructed from computed tomography imaging to facilitate understanding and support SDM. The impact of each counseling approach on SDM was evaluated using postintervention questionnaires. Results: A total of 47 participants were enrolled in this study. After analyzing the data, we found that patients in the MAR group showed significantly higher scores compared to those in the traditional counseling group (P<.001) during the SDM process. Moreover, patients reported higher satisfaction levels and found the visual objects helpful for understanding tumor location and surgical procedures. Conclusions: This study demonstrated that MAR counseling significantly enhanced patients’ comprehension of thoracic conditions and increased their active engagement in the SDM process (P<.001). The integration of patient-specific 3D anatomical models into MAR technology provided an intuitive method for critical medical information. This digital approach not only enhanced personalization in medical communication but also reinforced patient education about their health care conditions. These findings suggest that MAR counseling represents a promising approach for promoting patient-centered care in thoracic surgery and has potential applications across various clinical domains. Trial Registration: ClinicalTrials.gov NCT07062393; https://clinicaltrials.gov/study/NCT07062393
- 13 November 2025
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 13, e79632
Open AccessEffect of Mobile Augmented Reality Counseling on Improving Shared Decision-Making in Thoracic Surgery: Randomized Clinical Crossover Trial
Background: Augmented reality (AR) superimposes virtual objects onto a real-world environment, allowing users to interact in real time. As AR has become widely used, its integration into smartphones or tablets has enabled mobile augmented reality (MAR) experiences. AR has been adopted in many industries, and the literature has highlighted its applications in academic and clinical settings, particularly in enhancing visualization, communication, and learning. Objective: This study investigated the potential of MAR as a mobile health tool to enhance shared decision-making (SDM) in thoracic surgery by increasing patient understanding and engagement during medical consultations. Methods: A randomized crossover clinical trial was conducted at the Tri-Service General Hospital in Taiwan. Participants scheduled for thoracic surgery were enrolled and randomized in a crossover design. The MAR intervention incorporated patient-specific 3D anatomical models that were reconstructed from computed tomography imaging to facilitate understanding and support SDM. The impact of each counseling approach on SDM was evaluated using postintervention questionnaires. Results: A total of 47 participants were enrolled in this study. After analyzing the data, we found that patients in the MAR group showed significantly higher scores compared to those in the traditional counseling group (P<.001) during the SDM process. Moreover, patients reported higher satisfaction levels and found the visual objects helpful for understanding tumor location and surgical procedures. Conclusions: This study demonstrated that MAR counseling significantly enhanced patients’ comprehension of thoracic conditions and increased their active engagement in the SDM process (P<.001). The integration of patient-specific 3D anatomical models into MAR technology provided an intuitive method for critical medical information. This digital approach not only enhanced personalization in medical communication but also reinforced patient education about their health care conditions. These findings suggest that MAR counseling represents a promising approach for promoting patient-centered care in thoracic surgery and has potential applications across various clinical domains. Trial Registration: ClinicalTrials.gov NCT07062393; https://clinicaltrials.gov/study/NCT07062393
- Open Access
- 25 August 2025
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 58 (6) , 227-236
Epidermal Growth Factor Receptor Exon 20 Insertion in Early Resected Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study in Taiwan
Ying Shian Chen, M.D., Hsu-Kai Huang, M.D., Ying-Yi Chen, M.D., Yen-Shou Kuo, M.D., Kuan Hsun Lin, M.D., Cheng-Jung Lin, M.D., Tsai-Wang Huang, M.D., Ph.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.25.027
- 25 August 2025
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 58 (6) , 227-236
Open AccessEpidermal Growth Factor Receptor Exon 20 Insertion in Early Resected Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study in Taiwan
Ying Shian Chen, M.D., Hsu-Kai Huang, M.D., Ying-Yi Chen, M.D., Yen-Shou Kuo, M.D., Kuan Hsun Lin, M.D., Cheng-Jung Lin, M.D., Tsai-Wang Huang, M.D., Ph.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.25.027
- Open Access
- 25 June 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Effect of Mobile Augmented Reality Counseling on Improving Shared Decision-Making in Thoracic Surgery: Randomized Clinical Crossover Trial (Preprint)
BACKGROUND Augmented reality (AR) superimposes virtual objects onto a real-world environment, allowing users to interact in real time. As AR has become widely used, its integration into smartphones or tablets has enabled mobile augmented reality (MAR) experiences. AR has been adopted in many industries, and the literature has highlighted its applications in academic and clinical settings, particularly in enhancing visualization, communication, and learning. OBJECTIVE This study investigated the potential of MAR as a mobile health tool to enhance shared decision-making (SDM) in thoracic surgery by increasing patient understanding and engagement during medical consultations. METHODS A randomized crossover clinical trial was conducted at the Tri-Service General Hospital in Taiwan. Participants scheduled for thoracic surgery were enrolled and randomized in a crossover design. The MAR intervention incorporated patient-specific 3D anatomical models that were reconstructed from computed tomography imaging to facilitate understanding and support SDM. The impact of each counseling approach on SDM was evaluated using postintervention questionnaires. RESULTS A total of 47 participants were enrolled in this study. After analyzing the data, we found that patients in the MAR group showed significantly higher scores compared to those in the traditional counseling group (P<.001) during the SDM process. Moreover, patients reported higher satisfaction levels and found the visual objects helpful for understanding tumor location and surgical procedures. CONCLUSIONS This study demonstrated that MAR counseling significantly enhanced patients’ comprehension of thoracic conditions and increased their active engagement in the SDM process (P<.001). The integration of patient-specific 3D anatomical models into MAR technology provided an intuitive method for critical medical information. This digital approach not only enhanced personalization in medical communication but also reinforced patient education about their health care conditions. These findings suggest that MAR counseling represents a promising approach for promoting patient-centered care in thoracic surgery and has potential applications across various clinical domains. CLINICALTRIAL ClinicalTrials.gov NCT07062393; https://clinicaltrials.gov/study/NCT07062393
- 25 June 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEffect of Mobile Augmented Reality Counseling on Improving Shared Decision-Making in Thoracic Surgery: Randomized Clinical Crossover Trial (Preprint)
BACKGROUND Augmented reality (AR) superimposes virtual objects onto a real-world environment, allowing users to interact in real time. As AR has become widely used, its integration into smartphones or tablets has enabled mobile augmented reality (MAR) experiences. AR has been adopted in many industries, and the literature has highlighted its applications in academic and clinical settings, particularly in enhancing visualization, communication, and learning. OBJECTIVE This study investigated the potential of MAR as a mobile health tool to enhance shared decision-making (SDM) in thoracic surgery by increasing patient understanding and engagement during medical consultations. METHODS A randomized crossover clinical trial was conducted at the Tri-Service General Hospital in Taiwan. Participants scheduled for thoracic surgery were enrolled and randomized in a crossover design. The MAR intervention incorporated patient-specific 3D anatomical models that were reconstructed from computed tomography imaging to facilitate understanding and support SDM. The impact of each counseling approach on SDM was evaluated using postintervention questionnaires. RESULTS A total of 47 participants were enrolled in this study. After analyzing the data, we found that patients in the MAR group showed significantly higher scores compared to those in the traditional counseling group (P<.001) during the SDM process. Moreover, patients reported higher satisfaction levels and found the visual objects helpful for understanding tumor location and surgical procedures. CONCLUSIONS This study demonstrated that MAR counseling significantly enhanced patients’ comprehension of thoracic conditions and increased their active engagement in the SDM process (P<.001). The integration of patient-specific 3D anatomical models into MAR technology provided an intuitive method for critical medical information. This digital approach not only enhanced personalization in medical communication but also reinforced patient education about their health care conditions. These findings suggest that MAR counseling represents a promising approach for promoting patient-centered care in thoracic surgery and has potential applications across various clinical domains. CLINICALTRIAL ClinicalTrials.gov NCT07062393; https://clinicaltrials.gov/study/NCT07062393
- Open Access
- 19 October 2024
- Published by Medknow in Journal of Medical Sciences
- Vol. 45 (1) , 24-27
Lethal Complication of Postairway Stenting to Trachea and Left Main Bronchus: A Case Series with Discussion of the Diagnosis and Management
The insertion of a metallic airway stent is a valuable method for the treatment of benign and malignant airway stenosis and tracheoesophageal fistula. Although stenting for airway stenosis has become widely popular with favorable outcomes, several complications can arise after stenting, such as migration, tendency for stent fracture, and ingrowth of tumor or granulation tissue into the stent. Very few of these reports have described the complications of poststenting pneumothorax. We report the cases of three patients diagnosed with squamous cell carcinoma of the esophagus, complicated by tracheoesophageal fistula, and treated with a tracheal stent or bronchial stent, who developed poststenting pneumothorax.
- 19 October 2024
- Published by Medknow in Journal of Medical Sciences
- Vol. 45 (1) , 24-27
Open AccessLethal Complication of Postairway Stenting to Trachea and Left Main Bronchus: A Case Series with Discussion of the Diagnosis and Management
The insertion of a metallic airway stent is a valuable method for the treatment of benign and malignant airway stenosis and tracheoesophageal fistula. Although stenting for airway stenosis has become widely popular with favorable outcomes, several complications can arise after stenting, such as migration, tendency for stent fracture, and ingrowth of tumor or granulation tissue into the stent. Very few of these reports have described the complications of poststenting pneumothorax. We report the cases of three patients diagnosed with squamous cell carcinoma of the esophagus, complicated by tracheoesophageal fistula, and treated with a tracheal stent or bronchial stent, who developed poststenting pneumothorax.
- Open Access
- 16 March 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (6) , 1124
Diagnostic Performance of Electromagnetic Navigation versus Virtual Navigation Bronchoscopy-Guided Biopsy for Pulmonary Lesions in a Single Institution: Potential Role of Artificial Intelligence for Navigation Planning
Navigation bronchoscopy is an emerging technique used to evaluate pulmonary lesions. Using Veran’s SPiN electromagnetic navigation bronchoscopy (ENB) and Archimedes virtual bronchoscopy navigation (VBN), this study aimed to compare the accuracy and safety of these procedures for lung lesions and to identify potentially relevant knowledge for the application of artificial intelligence in interventional pulmonology in a single institute. This single-center, retrospective study compared the ENB and VBN results in patients with pulmonary lesions unsuitable for biopsy via percutaneous transthoracic needle biopsy methods. A total of 35 patients who underwent navigation bronchoscopy for pulmonary lesion diagnosis were enrolled. Nineteen patients were stratified in the ENB group, and sixteen were in the VBN group. The mean age of this cohort was 67.6 ± 9.9 years. The mean distance of the lesion from the pleural surface was 16.1 ± 11.7 mm (range: 1.0–41.0 mm), and most lesions were a solid pattern (n = 33, 94.4%). There were 32 cases (91.4%) of pulmonary lesions with an air-bronchus sign. A statistically significant difference was found between pulmonary size and transparenchymal nodule access (p = 0.049 and 0.037, respectively). The navigation success rate was significantly higher in the VBN group (93.8% vs. 78.9%). Moreover, no procedure-related complications or mortality were noted. The radiographic characteristics, such as size or solid component, can affect the selection of the biopsy procedure, either ENB or VBN. Navigation bronchoscopy-guided biopsy demonstrated acceptable accuracy and a good safety profile in evaluating pulmonary lesions when the percutaneous approach was challenging or life threatening.
- 16 March 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (6) , 1124
Open AccessDiagnostic Performance of Electromagnetic Navigation versus Virtual Navigation Bronchoscopy-Guided Biopsy for Pulmonary Lesions in a Single Institution: Potential Role of Artificial Intelligence for Navigation Planning
Navigation bronchoscopy is an emerging technique used to evaluate pulmonary lesions. Using Veran’s SPiN electromagnetic navigation bronchoscopy (ENB) and Archimedes virtual bronchoscopy navigation (VBN), this study aimed to compare the accuracy and safety of these procedures for lung lesions and to identify potentially relevant knowledge for the application of artificial intelligence in interventional pulmonology in a single institute. This single-center, retrospective study compared the ENB and VBN results in patients with pulmonary lesions unsuitable for biopsy via percutaneous transthoracic needle biopsy methods. A total of 35 patients who underwent navigation bronchoscopy for pulmonary lesion diagnosis were enrolled. Nineteen patients were stratified in the ENB group, and sixteen were in the VBN group. The mean age of this cohort was 67.6 ± 9.9 years. The mean distance of the lesion from the pleural surface was 16.1 ± 11.7 mm (range: 1.0–41.0 mm), and most lesions were a solid pattern (n = 33, 94.4%). There were 32 cases (91.4%) of pulmonary lesions with an air-bronchus sign. A statistically significant difference was found between pulmonary size and transparenchymal nodule access (p = 0.049 and 0.037, respectively). The navigation success rate was significantly higher in the VBN group (93.8% vs. 78.9%). Moreover, no procedure-related complications or mortality were noted. The radiographic characteristics, such as size or solid component, can affect the selection of the biopsy procedure, either ENB or VBN. Navigation bronchoscopy-guided biopsy demonstrated acceptable accuracy and a good safety profile in evaluating pulmonary lesions when the percutaneous approach was challenging or life threatening.
- Open Access
- 29 June 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (7) , 1066
Assessment of the Operative Feasibility and Ventilation Distribution during Nonintubation Thoracoscopic Surgery Using Electrical Impedance Tomography
Background: To investigate the feasibility, ventilation distribution, and physiological effect of iatrogenic pneumothorax generated during nonintubated thoracoscopic surgery using electrical impedance tomography. Methods: Patients who underwent resections for pulmonary nodules between April 2016 and April 2019 were enrolled prospectively. Electrical impedance tomography was performed, and the measurements were recorded at five different timepoints. The patient characteristics, pathological characteristics, surgical procedures, operation times, and intraoperative parameters were recorded and analyzed. Results: Two hundred sixty-five perioperative electrical impedance tomography measurements during nonintubated thoracoscopic surgery were recorded in fifty-three patients. Fifty-one patients underwent wedge resections, and two patients underwent segmentectomies. The preoperative lateral decubitus position time point showed greater ventilation in the right lung than in the left lung. For left-sided surgery, the nonoperative lung had better ventilation (64.5% ± 14.1% for the right side vs. 35.5% ± 14.1% for the left side, p < 0.0001). For right-sided surgery, the nonoperative lung did not have better ventilation (52.4% ± 16.1% for the right side vs. 47.6% ± 16.1% for the left side, p = 0.44). The center of ventilation was significantly increased after surgery (p < 0.001). The global index of ventilation showed no difference after surgery. Conclusions: The nonintubated thoracoscopic surgical side had different ventilation distributions but reached ventilation equilibrium after the operation. Electrical impedance tomography is feasible and safe for monitoring ventilation without adverse effects.
- 29 June 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (7) , 1066
Open AccessAssessment of the Operative Feasibility and Ventilation Distribution during Nonintubation Thoracoscopic Surgery Using Electrical Impedance Tomography
Background: To investigate the feasibility, ventilation distribution, and physiological effect of iatrogenic pneumothorax generated during nonintubated thoracoscopic surgery using electrical impedance tomography. Methods: Patients who underwent resections for pulmonary nodules between April 2016 and April 2019 were enrolled prospectively. Electrical impedance tomography was performed, and the measurements were recorded at five different timepoints. The patient characteristics, pathological characteristics, surgical procedures, operation times, and intraoperative parameters were recorded and analyzed. Results: Two hundred sixty-five perioperative electrical impedance tomography measurements during nonintubated thoracoscopic surgery were recorded in fifty-three patients. Fifty-one patients underwent wedge resections, and two patients underwent segmentectomies. The preoperative lateral decubitus position time point showed greater ventilation in the right lung than in the left lung. For left-sided surgery, the nonoperative lung had better ventilation (64.5% ± 14.1% for the right side vs. 35.5% ± 14.1% for the left side, p < 0.0001). For right-sided surgery, the nonoperative lung did not have better ventilation (52.4% ± 16.1% for the right side vs. 47.6% ± 16.1% for the left side, p = 0.44). The center of ventilation was significantly increased after surgery (p < 0.001). The global index of ventilation showed no difference after surgery. Conclusions: The nonintubated thoracoscopic surgical side had different ventilation distributions but reached ventilation equilibrium after the operation. Electrical impedance tomography is feasible and safe for monitoring ventilation without adverse effects.